凯普生物 (300639.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

200.8x

Market Cap

CNY 3.86B

MomentumView details →

1D Return

−3.40%

YTD Return

+9.67%

RSI (14)

48.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

200.8x

Market Cap

CNY 3.86B

RSI (14)

48.8

MomentumView details →

1D Return

−3.40%

YTD Return

+9.67%

ProfitabilityView details →

Gross Margin

44.50%

Net Margin

−16.09%

EBITDA Margin

2.29%

ROE (TTM)

−2.80%

ROA (TTM)

−2.52%

Asset Turnover

0.16x

GrowthView details →

Revenue YoY

−13.71%

EPS YoY

+83.98%

FCF YoY

+224.15%

Revenue CAGR 3Y

−50.72%

EPS CAGR 3Y

+79.41%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

5.30x

Quick Ratio

5.09x

Div Yield

—

Div Rate

—

Div Growth 1Y

−81.43%

Financials snapshotView financials →

Revenue (TTM)

661.41M

Net Income (TTM)

−106.43M

Op. CF (TTM)

319.64M

Latest newsMore news →

Hypro Biotechnology and its subsidiaries obtained a Chinese invention patent authorization for a sample tube fixing device and usage method in August 2026, which belongs to the in vitro diagnostic technology field.5d ago

Similar companies

恒辉安防300952.SZ 迦南智能300880.SZ 超达装备301186.SZ 山东海化000822.SZ 赛摩智能300466.SZ 皮阿诺002853.SZ Find similar companies →

Latest newsMore news →

Hypro Biotechnology and its subsidiaries obtained a Chinese invention patent authorization for a sample tube fixing device and usage method in August 2026, which belongs to the in vitro diagnostic technology field.5d ago